Ambrx Biopharma Inc - ADR (AMAM) shares closed 1.4% lower than its previous 52 week low, giving the company a market cap of $318M. The stock is currently down 6.3% year-to-date, down 50.4% over the past 12 months, and down 50.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%.
Trading Activity
- Trading volume this week was 59.9% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
Per Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -2217.9%
- The company's stock price performance over the past 12 months lags the peer average by 609.3%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
